R&D Pipeline

Innovative Therapies for the Brain and Immune System

At Tetra Pharm Technologies, we design and develop pharmaceutical drugs that target the central nervous system (CNS) and the immune system, with the goal of treating neurological diseases and psychiatric disorders.

Our drug candidates are engineered to deliver both immediate symptom relief and long-term disease-modifying effects. By carefully avoiding off-target interactions, our compounds are designed to offer an improved safety profile for patients.

Our current pipeline includes several lead compounds and formulations focused on obesity (with a neurological component), chronic pain, Alzheimer’s and mental health disorders.